One subgroup of this class are methylmethcathinones. Mephedrone, or 4-methylmethcathinone (4-MMC), appeared earlier on the market than its ortho- and meta-substituted isomers, 2-MMC and 3-MMC. It was mainly traded over the internet as a legal-high alternative for amphetamine (‘speed’) or cocaine. Similar to derivatization strategies for other drugs, when 4-MMC became a controlled substance, its uncontrolled derivatives 2-MMC and 3-MMC were introduced to the grey market. During 2020, a strong increase of cathinone seizures in Europe was reported by the European Monitoring Center for Drugs and Drug Addiction (EMCDDA) and the recently re-emerging 3-MMC made up for nearly ¼ of all seized cathinones.4
Before new legislations started regulating new psychoactive substances (NPS) based on general structural motifs, only specific substances were controlled and their derivates were not covered. While, the legal situation became easier with the introduction of these legislations, the executive authorities (custom border laboratories or other forensic analysis sites) are challenged with the detection of the continuously growing list of new designer drugs.
We have previously discussed the capability of benchtop NMR identifying both, similarities and differences in molecular structures even for almost identical substances and the methylmethcathinones are just another example. In Figure 2, the 60 MHz 1H NMR spectra of the regioisomers 2-MMC, 3-MMC, and 4-MMC are shown.